Sign in
Stories
AVITA Medical to Announce 2023 Financial Results and Discuss Regenerative Medicine
Share
Diabetic Foot Ulcers Market Set for Grow...
Revolutionizing Wellness Care in Chicago
ANJESO Drug Insight and Market Forecast
Afya Limited Expands Medical Seats in Br...
Beauty & Wellness Market Surge
Overview
API
AVITA Medical, Inc. will announce its fourth quarter and full year 2023 financial results after the close of the U.S. financial markets on February 22, 2024. The company's CEO and CFO will host a conference call and webcast to discuss financial results, business highlights, and future revenue guidance. AVITA Medical specializes in regenerative medicine, with the RECELL System approved for skin restoration and PermeaDerm, a Biosynthetic Wound Matrix, marketed in the United States.
Ask a question
How has AVITA Medical's RECELL System been performing in the market?
What are the key financial highlights expected in the fourth quarter and full year 2023 results?
What are the potential future revenue guidance for AVITA Medical?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage